• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EZH2-NF-κB调控轴驱动三阴性乳腺癌中促癌基因特征的表达。

An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer.

作者信息

Dardis Gabrielle J, Wang Jun, Simon Jeremy M, Wang Gang Greg, Baldwin Albert S

机构信息

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.

Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.

出版信息

iScience. 2023 Jun 14;26(7):107115. doi: 10.1016/j.isci.2023.107115. eCollection 2023 Jul 21.

DOI:10.1016/j.isci.2023.107115
PMID:37416481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10319845/
Abstract

The histone methyltransferase EZH2 has been studied most extensively in the context of PRC2-dependent gene repression. Accumulating evidence indicates non-canonical functions for EZH2 in cancer contexts including promoting paradoxical gene expression through interactions with transcription factors, including NF-κB in triple negative breast cancer (TNBC). We profile EZH2 and NF-κB factor co-localization and positive gene regulation genome-wide, and define a subset of NF-κB targets and genes associated with oncogenic functions in TNBC that is enriched in patient datasets. We demonstrate interaction between EZH2 and RelA requiring the recently identified transactivation domain (TAD) which mediates EZH2 recruitment to, and activation of certain NF-κB-dependent genes, and supports downstream migration and stemness phenotypes in TNBC cells. Interestingly, EZH2-NF-κB positive regulation of genes and stemness does not require PRC2. This study provides new insight into pro-oncogenic regulatory functions for EZH2 in breast cancer through PRC2-independent, and NF-κB-dependent regulatory mechanisms.

摘要

组蛋白甲基转移酶EZH2在PRC2依赖性基因抑制的背景下得到了最广泛的研究。越来越多的证据表明,EZH2在癌症背景下具有非经典功能,包括通过与转录因子相互作用促进矛盾的基因表达,如在三阴性乳腺癌(TNBC)中与NF-κB相互作用。我们在全基因组范围内分析了EZH2和NF-κB因子的共定位以及阳性基因调控,并确定了TNBC中与致癌功能相关的NF-κB靶标和基因子集,这些子集在患者数据集中富集。我们证明了EZH2和RelA之间的相互作用需要最近鉴定的反式激活域(TAD),该域介导EZH2募集到某些NF-κB依赖性基因并激活这些基因,并支持TNBC细胞中的下游迁移和干性表型。有趣的是,EZH2-NF-κB对基因和干性的正向调控不需要PRC2。这项研究通过不依赖PRC2且依赖NF-κB的调控机制,为EZH2在乳腺癌中的促癌调控功能提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/71bb83aaa956/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/d0a38d98ebfc/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/91164d15d23c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/4f83d6d2be03/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/29b5eae49514/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/07fa58e7e555/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/6abedf324f10/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/f285bcd9ad45/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/71bb83aaa956/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/d0a38d98ebfc/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/91164d15d23c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/4f83d6d2be03/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/29b5eae49514/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/07fa58e7e555/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/6abedf324f10/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/f285bcd9ad45/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e8/10319845/71bb83aaa956/gr7.jpg

相似文献

1
An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer.EZH2-NF-κB调控轴驱动三阴性乳腺癌中促癌基因特征的表达。
iScience. 2023 Jun 14;26(7):107115. doi: 10.1016/j.isci.2023.107115. eCollection 2023 Jul 21.
2
Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers.EZH2 通过调控 NF-κB 靶基因表达在乳腺癌中具有组织特异性。
Mol Cell. 2011 Sep 2;43(5):798-810. doi: 10.1016/j.molcel.2011.08.011.
3
Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer.非经典EZH2在三阴性乳腺癌中对RelB进行转录激活。
PLoS One. 2016 Oct 20;11(10):e0165005. doi: 10.1371/journal.pone.0165005. eCollection 2016.
4
Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.乙型肝炎病毒X蛋白通过RelA与EZH2和TET2形成复合物所介导的活性DNA去甲基化作用诱导上皮细胞黏附分子(EpCAM)的表达。
Oncogene. 2016 Feb 11;35(6):715-26. doi: 10.1038/onc.2015.122. Epub 2015 Apr 20.
5
Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.硝酰脂肪酸抑制三阴性乳腺癌细胞活力、迁移、侵袭和肿瘤生长。
J Biol Chem. 2018 Jan 26;293(4):1120-1137. doi: 10.1074/jbc.M117.814368. Epub 2017 Nov 20.
6
Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription.节律基因 NFIL3 的高表达通过抑制 NFKBIA 转录来激活 NF-κB 信号通路,从而促进三阴性乳腺癌的进展。
J Exp Clin Cancer Res. 2022 Feb 18;41(1):67. doi: 10.1186/s13046-022-02260-1.
7
IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts.IΚΚε 在不同的环境下与 MEK 或非经典 NF-κB 合作,促进三阴性乳腺癌细胞的生长。
BMC Cancer. 2018 May 25;18(1):595. doi: 10.1186/s12885-018-4507-2.
8
Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57 and involving in p-p38 MAPK and NF-κB pathways.长链非编码 RNA TALNEC2 通过与 EZH2 结合靶向 p57 在乳腺癌中发挥致癌作用,并涉及 p-p38 MAPK 和 NF-κB 途径。
J Cell Biochem. 2019 Mar;120(3):3978-3988. doi: 10.1002/jcb.27680. Epub 2018 Oct 30.
9
EZH2 promotes migration and invasion of triple-negative breast cancer cells via regulating TIMP2-MMP-2/-9 pathway.EZH2通过调节TIMP2-MMP-2/-9信号通路促进三阴性乳腺癌细胞的迁移和侵袭。
Am J Cancer Res. 2018 Mar 1;8(3):422-434. eCollection 2018.
10
EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis.EZH2 通过一个隐藏的反式激活结构域非canonically 结合 cMyc 和 p300,以介导基因激活并促进肿瘤发生。
Nat Cell Biol. 2022 Mar;24(3):384-399. doi: 10.1038/s41556-022-00850-x. Epub 2022 Feb 24.

引用本文的文献

1
MMP-9 Activation via ROS/NF-κB Signaling in Colorectal Cancer Progression: Molecular Insights and Prognostic-Therapeutic Perspectives.通过ROS/NF-κB信号通路激活MMP-9在结直肠癌进展中的作用:分子机制及预后治疗前景
Curr Issues Mol Biol. 2025 Jul 17;47(7):557. doi: 10.3390/cimb47070557.
2
Reducing batch effects in single cell chromatin accessibility measurements by pooled transposition with MULTI-ATAC.通过使用MULTI-ATAC的混合转座减少单细胞染色质可及性测量中的批次效应。
bioRxiv. 2025 Feb 17:2025.02.14.638353. doi: 10.1101/2025.02.14.638353.
3
Genetic variation in IL-4 activated tissue resident macrophages determines strain-specific synergistic responses to LPS epigenetically.

本文引用的文献

1
A cryptic transactivation domain of EZH2 binds AR and AR's splice variant, promoting oncogene activation and tumorous transformation.EZH2 的一个隐匿反式激活结构域与 AR 及其剪接变异体结合,促进癌基因激活和肿瘤转化。
Nucleic Acids Res. 2022 Oct 28;50(19):10929-10946. doi: 10.1093/nar/gkac861.
2
Role of syndecan-4 in breast cancer pathophysiology.Syndecan-4在乳腺癌病理生理学中的作用。
Am J Physiol Cell Physiol. 2022 Nov 1;323(5):C1345-C1354. doi: 10.1152/ajpcell.00152.2022. Epub 2022 Sep 12.
3
Depletion of CCN1/CYR61 reduces triple-negative/basal-like breast cancer aggressiveness.
白细胞介素-4激活的组织驻留巨噬细胞中的基因变异在表观遗传上决定了对脂多糖的品系特异性协同反应。
Nat Commun. 2025 Jan 25;16(1):1030. doi: 10.1038/s41467-025-56379-8.
4
Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities.探索EZH2的致癌作用及临床意义:聚焦于非经典活性
Ther Adv Med Oncol. 2025 Jan 7;17:17588359241306026. doi: 10.1177/17588359241306026. eCollection 2025.
5
Integration of epigenomic and transcriptomic profiling uncovers EZH2 target genes linked to cysteine metabolism in hepatocellular carcinoma.整合表观基因组和转录组谱分析揭示 EZH2 靶基因与肝细胞癌中半胱氨酸代谢的关联。
Cell Death Dis. 2024 Nov 8;15(11):801. doi: 10.1038/s41419-024-07198-0.
6
DAB2IP loss in luminal a breast cancer leads to NF-κB-associated aggressive oncogenic phenotypes.腔面A型乳腺癌中DAB2IP缺失导致与NF-κB相关的侵袭性致癌表型。
JCI Insight. 2024 Dec 6;9(23):e171705. doi: 10.1172/jci.insight.171705.
7
EZH2 functional dichotomy in reactive oxygen species-stratified glioblastoma.活性氧分层胶质母细胞瘤中EZH2的功能二分法
Neuro Oncol. 2025 Feb 10;27(2):398-414. doi: 10.1093/neuonc/noae206.
8
RBM39 Enhances Cholangiocarcinoma Growth Through EZH2-mediated WNT7B/β-catenin Pathway.RBM39通过EZH2介导的WNT7B/β-连环蛋白信号通路促进胆管癌生长。
Cell Mol Gastroenterol Hepatol. 2025;19(1):101404. doi: 10.1016/j.jcmgh.2024.101404. Epub 2024 Sep 14.
9
EZH2 Inhibition to Counteract Oral Cancer Progression through Wnt/β-Catenin Pathway Modulation.通过Wnt/β-连环蛋白信号通路调控抑制EZH2以对抗口腔癌进展
Pharmaceuticals (Basel). 2024 Aug 22;17(8):1102. doi: 10.3390/ph17081102.
10
Identification of Poliovirus Receptor-like 3 Protein as a Prognostic Factor in Triple-Negative Breast Cancer.鉴定脊髓灰质炎病毒受体样 3 蛋白作为三阴性乳腺癌的预后因素。
Cells. 2024 Aug 3;13(15):1299. doi: 10.3390/cells13151299.
CCN1/CYR61 的缺失可降低三阴性/基底样乳腺癌的侵袭性。
Am J Cancer Res. 2022 Feb 15;12(2):839-851. eCollection 2022.
4
EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis.EZH2 通过一个隐藏的反式激活结构域非canonically 结合 cMyc 和 p300,以介导基因激活并促进肿瘤发生。
Nat Cell Biol. 2022 Mar;24(3):384-399. doi: 10.1038/s41556-022-00850-x. Epub 2022 Feb 24.
5
Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs.针对癌症治疗的胚胎外胚层发育(EED)的最新策略:别构抑制剂、PPI 抑制剂和 PROTACs。
Eur J Med Chem. 2022 Mar 5;231:114144. doi: 10.1016/j.ejmech.2022.114144. Epub 2022 Jan 20.
6
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer.雄激素受体开关是导致治疗抵抗性前列腺癌谱系不忠实的基础。
Nat Cell Biol. 2021 Sep;23(9):1023-1034. doi: 10.1038/s41556-021-00743-5. Epub 2021 Sep 6.
7
microRNA-140-3p modulates invasiveness, motility, and extracellular matrix adhesion of breast cancer cells by targeting syndecan-4.microRNA-140-3p 通过靶向结合 syndecan-4 调控乳腺癌细胞的侵袭、迁移和细胞外基质黏附。
J Cell Biochem. 2021 Oct;122(10):1491-1505. doi: 10.1002/jcb.30071. Epub 2021 Jun 27.
8
CHPF promotes malignancy of breast cancer cells by modifying syndecan-4 and the tumor microenvironment.CHPF通过修饰syndecan-4和肿瘤微环境促进乳腺癌细胞的恶性发展。
Am J Cancer Res. 2021 Mar 1;11(3):812-826. eCollection 2021.
9
Noncanonical Functions of the Polycomb Group Protein EZH2 in Breast Cancer.抑癌基因 EZH2 在乳腺癌中的非典型功能。
Am J Pathol. 2021 May;191(5):774-783. doi: 10.1016/j.ajpath.2021.01.013. Epub 2021 Feb 6.
10
Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease.表观遗传学及其他:以蛋白质赖氨酸甲基化写作者为靶点治疗疾病。
Nat Rev Drug Discov. 2021 Apr;20(4):265-286. doi: 10.1038/s41573-020-00108-x. Epub 2021 Jan 19.